Thorne HealthTech (NasdaqGS:THRN) - Share price, News & Analysis

THRN fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	5/6
Past Performance	3/6
Financial Health	4/6
Dividends	0/6

THRN Stock Overview

Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally.

Rewards

Earnings are forecast to grow 76.38% per year

Became profitable this year

Risk Analysis

No risks detected for THRN from our risk checks.

Thorne HealthTech Competitors

Nature's Sunshine Products

NasdaqCM:NATR

US$198.8m

LFTD Partners

OTCPK:LIFD

US$95.2m

Grove

NasdaqCM:GRVI

US$89.0m

United-Guardian

NasdaqGM:UG

US$71.5m

Price History & Performance

Summary of all time highs, changes and price drops for Thorne HealthTech
Historical stock prices
Current Share Price	US$5.40
52 Week High	US$10.13
52 Week Low	US$4.00
Beta	0
1 Month Change	13.92%
3 Month Change	-13.04%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-28.48%

Recent News & Updates

Aug 09

Thorne HealthTech swings to Q2 Non-GAAP loss per share, revenue down Y/Y, FY22 guidance revised

Thorne HealthTech press release (NASDAQ:THRN): Q2 Non-GAAP EPS of -$0.05 (vs. $0.22 Y/Y). Revenue of $56.1M (+30.8% Y/Y). FY22 guidance revised to net sales of $235M to $242M (vs. consensus of $247.13M) and EPS of of $0.36 to $0.39 (vs. consensus of $0.34). Shares -1.47% AH.

Shareholder Returns

	THRN	US Personal Products	US Market
7D	-10.2%	2.0%	3.6%
1Y	n/a	-18.1%	-9.6%

Return vs Industry: Insufficient data to determine how THRN performed against the US Personal Products industry.

Return vs Market: Insufficient data to determine how THRN performed against the US Market.

Price Volatility

Is THRN's price volatile compared to industry and market?
THRN volatility
THRN Average Weekly Movement	8.2%
Personal Products Industry Average Movement	10.7%
Market Average Movement	7.7%
10% most volatile stocks in US Market	16.9%
10% least volatile stocks in US Market	3.2%

Stable Share Price: THRN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: THRN's weekly volatility (8%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1984	496	Paul Jacobson	https://www.thorne.com

Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual’s health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to improve and maintain their health.

Thorne HealthTech Fundamentals Summary

How do Thorne HealthTech's earnings and revenue compare to its market cap?
THRN fundamental statistics
Market Cap	US$284.81m
Earnings (TTM)	US$3.13m
Revenue (TTM)	US$208.61m

90.9x

P/E Ratio

1.4x

P/S Ratio

Is THRN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
THRN income statement (TTM)
Revenue	US$208.61m
Cost of Revenue	US$95.91m
Gross Profit	US$112.70m
Other Expenses	US$109.57m
Earnings	US$3.13m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	0.059
Gross Margin	54.03%
Net Profit Margin	1.50%
Debt/Equity Ratio	1.1%

How did THRN perform over the long term?

See historical performance and comparison

We’ve recently updated our valuation analysis.

Valuation

Is THRN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for THRN?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for THRN. This is calculated by dividing THRN's market cap by their current preferred multiple.
What is THRN's n/a Ratio?
n/a Ratio	0x
n/a	n/a
Market Cap	US$284.81m

THRN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.4x
Enterprise Value/EBITDA	76.9x
PEG Ratio	1.2x

Price to Earnings Ratio vs Peers

How does THRN's PE Ratio compare to its peers?

THRN PE Ratio vs Peers

The above table shows the PE ratio for THRN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	PE	Estimated Growth	Market Cap
Peer Average	17.6x
NATR Nature's Sunshine Products	12.8x	25.3%	US$198.8m
LIFD LFTD Partners	9.8x	n/a	US$95.2m
GRVI Grove	27.9x	n/a	US$89.0m
UG United-Guardian	20.1x	n/a	US$71.5m
THRN Thorne HealthTech	90.9x	76.4%	US$284.8m

Price-To-Earnings vs Peers: THRN is expensive based on its Price-To-Earnings Ratio (90.9x) compared to the peer average (17.6x).

Price to Earnings Ratio vs Industry

How does THRN's PE Ratio compare vs other companies in the US Personal Products Industry?

Price-To-Earnings vs Industry: THRN is expensive based on its Price-To-Earnings Ratio (90.9x) compared to the US Personal Products industry average (19.4x)

Price to Earnings Ratio vs Fair Ratio

What is THRN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

THRN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	90.9x
Fair PE Ratio	47.5x

Price-To-Earnings vs Fair Ratio: THRN is expensive based on its Price-To-Earnings Ratio (90.9x) compared to the estimated Fair Price-To-Earnings Ratio (47.5x).

Share Price vs Fair Value

What is the Fair Price of THRN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate THRN's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate THRN's fair value for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Future Growth

How is Thorne HealthTech forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

Future Growth Score

5/6

Future Growth Score 5/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

76.4%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: THRN's forecast earnings growth (76.4% per year) is above the savings rate (1.9%).

Earnings vs Market: THRN's earnings (76.4% per year) are forecast to grow faster than the US market (14.5% per year).

High Growth Earnings: THRN's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: THRN's revenue (28.9% per year) is forecast to grow faster than the US market (7.9% per year).

High Growth Revenue: THRN's revenue (28.9% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if THRN's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Past Performance

How has Thorne HealthTech performed over the past 5 years?

Past Performance Score

3/6

Past Performance Score 3/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

28.5%

Last years revenue growth

Earnings and Revenue History

Quality Earnings: THRN has high quality earnings.

Growing Profit Margin: THRN became profitable in the past.

Past Earnings Growth Analysis

Earnings Trend: THRN has become profitable over the past 5 years.

Accelerating Growth: THRN has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: THRN has become profitable in the last year, making it difficult to compare its past year earnings growth to the Personal Products industry (4.3%).

Return on Equity

High ROE: THRN's Return on Equity (1.1%) is considered low.

Discover strong past performing companies

Financial Health

How is Thorne HealthTech's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage

Financial Position Analysis

Short Term Liabilities: THRN's short term assets ($100.6M) exceed its short term liabilities ($34.6M).

Long Term Liabilities: THRN's short term assets ($100.6M) exceed its long term liabilities ($29.7M).

Debt to Equity History and Analysis

Debt Level: THRN has more cash than its total debt.

Reducing Debt: Insufficient data to determine if THRN's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: THRN's debt is well covered by operating cash flow (89.2%).

Interest Coverage: Insufficient data to determine if THRN's interest payments on its debt are well covered by EBIT.

Balance Sheet

Discover healthy companies

Dividend

What is Thorne HealthTech current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Cash Flow Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate THRN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate THRN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if THRN's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if THRN's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as THRN has not reported any payouts.

Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

8.6yrs

Average management tenure

CEO

Paul Jacobson (67 yo)

12.58yrs

Tenure

US$12,906,400

Compensation

Mr. Paul F. Jacobson Co-Founded Thorne HealthTech, Inc. in 2010 and has been its Chief Executive Officer and Director since 2010. He is Chairman of Thorne HealthTech, Inc. He serves as the Chief Executive...

CEO Compensation Analysis

Compensation vs Market: Paul's total compensation ($USD12.91M) is above average for companies of similar size in the US market ($USD1.67M).

Compensation vs Earnings: Paul's compensation has been consistent with company performance over the past year.

Leadership Team

Experienced Management: THRN's management team is seasoned and experienced (8.6 years average tenure).

Board Members

Experienced Board: THRN's board of directors are considered experienced (3.8 years average tenure).

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: THRN only recently listed within the past 12 months.

Data	Last Updated (UTC time)
Company Analysis	2022/08/15 00:00
End of Day Share Price	2022/08/15 00:00
Earnings	2022/06/30
Annual Earnings	2021/12/31